Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A. S. Krikovtsov"'
Autor:
A. V. Shabalin, E. N. Gulyaeva, S. V. Myshkin, I. V. Kolyshkina, L. L. Gorbunova, A. S. Krikovtsov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 4, Iss 6, ч.II, Pp 10-15 (2005)
Aim. To study the prevalence of arterial hypertension (AH) risk factors (RF), and their association, in Kemerovo City penitentiary system (KCPS) personnel. Material and methods. In total, 248 individuals (73% males, 27% females), aged 20-39 (mean age
Externí odkaz:
https://doaj.org/article/5caff90e4dec468fba2dc0bc9beb3ec9
Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 4, Iss 6, ч.I, Pp 31-37 (2005)
Aim. To study clinical effectiveness of eprosartan mesylate in treating patients with Stage I-II arterial hypertension (AH). Material and methods. In total, 28 patients (20 males, 8 females) with Stage I-II AH, risk 2-3, aged 28-56 years (mean age 40
Externí odkaz:
https://doaj.org/article/770e670dbce54396b10876e3200a1caa
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 11:261-264
The association of clinical and functional parameters was studied in patients with mild and moderate arterial hypertension (All) during therapy with betaxolol (Lokren), Twenty six patients (19 males and 7 females) aged 28 to 56 (mean 40.5 ± 1.4) yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa20ee8496de11f1f5494001922e38dc
https://doi.org/10.18705/1607-419x-2005-11-4-261-264
https://doi.org/10.18705/1607-419x-2005-11-4-261-264
Autor:
Ye. Ye. Torochkina, A. S. Krikovtsov, O. V. Kovalenko, A. V. Shabalin, Ye. N. Gulyaeva, E. M. Verkoshanskaya
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 10:39-42
The clinical significance of heart rate variability and Q-T interval duration during 24-hour bifunctional monitoring of ECG and blood pressure (BP) was studied in 81 patients aged 22-58 years (mean 41,40±0,72 years) who had Stages I-III essential hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c18b49a6c129b85dfe72aa47d2eda90
https://doi.org/10.18705/1607-419x-2004-10-1-39-42
https://doi.org/10.18705/1607-419x-2004-10-1-39-42
Autor:
A V, Shabalin, E N, Guliaeva, E E, Torochkina, E M, Verkoshanskaia, O V, Kovalenko, S V, Myshkin, A S, Krikovtsov
Publikováno v:
Kardiologiia. 45(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::993ec743c22952d4a3bfe2f9dcaa815c
https://pubmed.ncbi.nlm.nih.gov/16091641
https://pubmed.ncbi.nlm.nih.gov/16091641
Autor:
A S, Krikovtsov, L S, Barbarash
Publikováno v:
Klinicheskaia khirurgiia. (7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69d973116a24b47187984273f1901200
https://pubmed.ncbi.nlm.nih.gov/1942841
https://pubmed.ncbi.nlm.nih.gov/1942841